How do I buy Adaptive Biotechnologies (ADPT) stock?

You can purchase shares of Adaptive Biotechnologies (NASDAQ:ADPT) through any online brokerage.View our list of the best stock brokerages

Who are Adaptive Biotechnologies (ADPT) competitors?

Other companies in Adaptive Biotechnologies’s space includes: Medpace Holdings Inc (NASDAQ:MEDP), Agilent Technologies Inc (NYSE:A), Icon PLC (NASDAQ:ICLR), 10x Genomics Inc (NASDAQ:TXG) and Waters Corp (NYSE:WAT).

What is the forecast, or price target, for Adaptive Biotechnologies (ADPT) stock?

Adaptive Biotechnologies has a consensus price target of $15.73.

What is the current price for Adaptive Biotechnologies (ADPT)?

The stock price for Adaptive Biotechnologies (NASDAQ: ADPT) is $17.15 last updated January 20, 2026 at 7:51 AM EST.

Does Adaptive Biotechnologies (ADPT) pay a dividend?

There are no upcoming dividends for Adaptive Biotechnologies.

When is Adaptive Biotechnologies (NASDAQ:ADPT) reporting earnings?

Adaptive Biotechnologies does not have any upcoming earnings scheduled.

Is Adaptive Biotechnologies (ADPT) going to split?

There is no upcoming split for Adaptive Biotechnologies.

What sector and industry does Adaptive Biotechnologies (ADPT) operate in?

Adaptive Biotechnologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Adaptive Biotechnologies (ADPT) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

Comments